Table 2.
Characteristics | Weekday discharge (N = 138) |
Weekend discharge (N = 79) |
p value |
---|---|---|---|
Female | 43 (31) | 29 (37) | ns |
SAPS II | 37 (26 - 46) | 36 (23 - 43) | ns |
Days in ICU | 10 (6 - 18) | 10 (5 - 22) | ns |
Origin | ns | ||
Room | 22 (16) | 15 (19) | |
Surgical block | 33 (24) | 20 (25) | |
Emergency | 78 (56) | 41 (52) | |
Another hospital | 6 (4) | 3 (4) | |
IMV | 103 (75) | 61 (79) | ns |
Vasoactive drugs | 63 (46) | 30 (39) | ns |
RRT | 8 (6) | 6 (8) | ns |
Central venous access | 133 (97) | 73 (95) | ns |
Arterial access | 81 (58) | 42 (55) | ns |
Comorbidities | ns | ||
EPOC | 25 (18) | 23 (29) | |
Cardiopathy | 29 (21) | 22 (28) | |
Cancer | 2 (1,5) | 4 (5) | |
CKD | 7 (5) | 4 (5) | |
HIV | 5 (3,5) | 1 (1,5) | |
Tracheostomy | 33 (24) | 27 (35) | ns |
Hospital stay | 21(12 - 29,5) | 16 (9,75 - 29) | ns |
LTE | 7 (5) | 5 (6) | ns |
Died in the hospital | 19 (14) | 45 (57) | 0,000 |
ns - non-significant; SAPS II - Simplified Acute Physiology Score II; ICU - intensive care unit; IMV - invasive mechanical ventilation; RRT - renal replacement therapy; COPD - chronic obstructive pulmonary disease; CKD - chronic kidney disease; HIV - human immunodeficiency virus; LTE - limitation of therapeutic effort. The results are expressed as percentage or median (25% - 75%).